[CLINICAL CONSIDERATIONS ON THE ACTIVITY AND POSSIBILITY OF USE OF A NEW ORAL HYPOGLYCEMIC BASED ON A COMBINATION OF CHLORPROPAMIDE AND PHENETHYLBIGUANIDE IN VARIOUS TYPES OF DIABETES MELLITUS].
D035843:Biomedical Research; D002747:Chlorpropamide; D003920:Diabetes Mellitus; D006801:Humans; D007004:Hypoglycemic Agents; D010629:Phenformin
D007004:Hypoglycemic Agents; D010629:Phenformin; D002747:Chlorpropamide
CHLORPROPAMIDE; CLINICAL RESEARCH; DIABETES MELLITUS; PHENFORMIN
CONSIDERAZIONI CLINICHE SULL'ATTIVIT'A E SULLE POSSIBILIT'A DI IMPIEGO DI UN NUOVO IPOGLICEMIZZANTE ORALE A BASE DI ASSOCIAZIONE CLORPROPAMIDE-FENETILBIGUANIDE NELLE VARIE FORME DI DIABETE MELLITO.